The global invasive brain–computer interface (BCI) total addressable market was valued at USD 160.44 billion in 2024 and is projected to grow at a CAGR of 1.49% from 2025 to 2030. Multiple research studies indicate that invasive BCI technologies offer a higher likelihood of restoring motor function and communication abilities in patients suffering from neurological conditions such as amyotrophic lateral sclerosis (ALS), spinal cord injuries, and stroke. These systems enable direct interaction between the brain and external devices, making them particularly valuable for severe neurological impairments.
In contrast, the global non-invasive brain–computer interface serviceable obtainable market was estimated at USD 368.60 million in 2024 and is expected to expand at a significantly higher CAGR of 9.35% from 2025 to 2030. Growth in this segment is driven by the rising prevalence of neurological disorders requiring neuroprosthetic and assistive technologies, the expanding global elderly population, and continuous technological advancements that improve communication and mobility for patients with paralysis. Additionally, the growing adoption of non-invasive BCI technology in home automation, virtual gaming, rehabilitation, and military communication systems is broadening its application scope and accelerating market growth.
Order a free sample PDF**** of the Brain Computer Interface Market Intelligence Study, published by Grand View Research.
Key Brain Computer Interface Company Insights
The brain–computer interface market comprises a mix of established multinational corporations and emerging technology firms. Prominent players include Natus Medical Incorporated, Brain Products GmbH, Compumedics Neuroscan, EMOTIV, and NeuroSky, among others. The presence of numerous small- and large-scale manufacturers has resulted in intense competition, driving innovation and rapid technological advancement across the industry.
To strengthen their market positions, industry participants are increasingly focusing on strategic initiatives such as mergers and acquisitions, new product launches, partnerships, and collaborations. These strategies are aimed at expanding product portfolios, enhancing technological capabilities, and capturing a larger share of the growing market.
In March 2024, Neurable Inc. announced a strategic collaboration with Healthspan Digital Inc. to commercialize Neurable’s brain health tools. This partnership aims to equip precision health and longevity clinics with advanced brain-span technology designed to enhance cognitive performance and overall brain health. The collaboration represents a significant step toward integrating BCI technology into precision health and wellness solutions.
Key Companies Profiled
Recent Developments
Conclusion
The brain–computer interface market is evolving rapidly, supported by advancements in neural engineering, increasing neurological disorder prevalence, and expanding applications across healthcare, consumer technology, and defense. While invasive BCIs continue to demonstrate strong clinical potential for restoring lost functions, non-invasive systems are gaining momentum due to their broader accessibility and expanding use cases. Continued innovation, strategic collaborations, and real-world clinical successes are expected to shape the future growth of the global BCI market.